Article: Antibody-drug conjugates in the treatment of haematological malignancies

Related products

• 

  1 year subscription print edition of the Belgian Journal of Hematology (BJH)

  €147.15 Add to cart
• 

  Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma

  €2.42 Add to cart
• 

  Article: INTRODUCTION

  €2.42 Add to cart
• 

  Article: Highlights in breast cancer

  €2.42 Add to cart